Funded Tech Companies
Pionyr Immunotherapeutics
Looking for the VC firms that backed Pionyr Immunotherapeutics? Gilead Sciences, OrbiMed and New Enterprise Associates invested in this biopharmaceutical company.
Company Overview
Company Name
Pionyr Immunotherapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2 Tower Pl. 800
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
Pionyr develops drugs to perform exceptional fine-tuning of immune responses. This goal addresses a current and justified excitement about immunotherapy and introduces technology to rapidly identify and target novel arms of the immune response, within the tumor microenvironment (TME).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/24/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven James
Chief Financial Officer
Monte Montgomery
Chief Medical Officer
Leonard Reyno
Chief Scientific Officer
Michel Streuli
Vice President
Kevin Baker
Vice President
Evan Greger
VP - Bus. Development
Alicia Levey
VP - Operations
Michael Ellis
Company Investors
- Gilead Sciences (Daniel O'Day)
- OrbiMed (Leon Chen)
- New Enterprise Associates (Carol Gallagher)
- Osage Partners
- SV Health Investors (Joshua Resnick)
- Vida Ventures (Arjun Goyal)
- Sofinnova Ventures (Michael Powell)
- Mission Bay Capital
- Private Investors (Bill Rieflin)
- Private Investors (John Freund)
- Private Investors (Stephen Hoffman)
- Private Investors (Yasunori Kaneko)
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs